Which clinical trial provides evidence that the Somogyi phenomenon is not a true rebound hyperglycemia after nocturnal hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Which Trial Supports That the Somogyi Phenomenon Is Not True Rebound Hyperglycemia?

The landmark 1987 New England Journal of Medicine study by Torbjörnsdotter et al. 1 provides the definitive evidence that nocturnal hypoglycemia does not cause fasting hyperglycemia in insulin-dependent diabetes patients.

Key Study Design and Findings

This controlled trial studied 10 insulin-dependent diabetes patients over three nights with different interventions:

  • Control night: Blood sampling only
  • Prevention night: IV glucose to keep plasma glucose >100 mg/dL (5.6 mmol/L)
  • Induction night: IV insulin to induce hypoglycemia <50 mg/dL (2.8 mmol/L) between midnight and 4 AM

Critical Results

After inducing nocturnal hypoglycemia (mean 36 mg/dL), the 8 AM fasting glucose was 113 mg/dL - actually lower than when hypoglycemia was prevented (182 mg/dL) or on control nights (149 mg/dL) 1.

Most importantly, regression analysis showed fasting glucose was directly - not inversely - related to the nocturnal glucose nadir (r = 0.761, P = 0.011) 1. This means lower overnight glucose predicted lower morning glucose, the exact opposite of what the Somogyi effect would predict.

Supporting Evidence

The 1990 follow-up study in Diabetes Care extended these findings to daytime glucose levels 2. After inducing nocturnal hypoglycemia (1.9 mmol/L), fasting and entire-day plasma glucose concentrations were no higher than after preventing hypoglycemia. Again, daytime glucose levels were directly related to the nocturnal nadir (r = 0.714, P < 0.02) 2.

Modern Confirmation

Recent large-scale continuous glucose monitoring studies have definitively confirmed these findings:

  • A 2022 study of 2,600 type 2 diabetes patients found morning fasting glucose was lower after nights with nocturnal hypoglycemia (P < 0.001), with strong positive correlation between nocturnal nadir and fasting glucose (r = 0.613, P < 0.001) 3
  • A 2013 UK study of 89 type 1 diabetes patients found fasting glucose was lower after nocturnal hypoglycemia [5.5 vs 14.5 mmol/L, P < 0.0001], with only 2 instances of rebound hyperglycemia out of hundreds of nights analyzed 4

Clinical Implications

The mechanism behind apparent "rebound" hyperglycemia is waning insulin effect, not counter-regulatory hormone excess 5. When hyperglycemia does occur after hypoglycemia, it reflects relative insulin deficiency in the latter part of the night, not hormonal rebound 5.

Common Pitfall to Avoid

Do not reduce insulin doses when patients present with fasting hyperglycemia out of fear of nocturnal hypoglycemia. If fasting glucose exceeds 9.6 mmol/L (173 mg/dL), there is essentially no risk of nocturnal hypoglycemia 3. Conversely, fasting glucose ≤5 mmol/L (90 mg/dL) indicates nocturnal hypoglycemia occurred on 94% of nights 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.